Music Therapy for Parkinson's Disease (Amped-PD Trial)

"Adhering to the participation requirements of this clinical trial, the minimum age for enrolment is 40 years old and upper limit is 80."

"Clinicialtrials.gov confirms that this medical study is still recruiting patients, after debuting on August 1st 2022 and receiving an update on September 19th 2022."

"This medical trial is currently recruiting 44 participants aged between 40 and 80 who have been diagnosed with idiopathic Parkinson's disease. To be eligible, patients must also meet a set of criteria including: modified Hoehn & Yahr stages 1-3 per physical examination by an accredited therapist, able to walk independently for 10 minutes or more without aid from assistive devices or other people, consistent PD medication regimen for two weeks prior to enrollment, willing and capable of providing informed consent along with HIPAA Authorization granting communication rights between the patient and their primary care physician."

"Confirmed. Clinicaltrials.gov displays that this trial, which was activated on August 1st of 2022, is still recruiting patients to participate in the study. A total of 44 participants must be sourced from a single medical site."

"This clinical trial seeks to evaluate gait quality by measuring stride length variability over a two-week follow-up period. Secondary outcomes include the Geriatric Depression Scale (GDS), Parkinson's disease Questionnaire - 39 (PDQ-39) and the 10 Meter Walk Test (10MWT). The GDS is composed of yes/no questions, with higher scores representing increased depression levels up to 15 points. The PDQ-39 measures patient quality of life using an ordinal 5 point system, while lower numbers indicate better wellbeing up to 100 points. Lastly, the 10MWT evaluates short distance walking function at both comfortable and maximum"